OKUR – onkure therapeutics, inc. - class a (US:NASDAQ)
Stock Stats
News
OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at HC Wainwright from $40.00 to $34.00. They now have a "buy" rating on the stock.
Will OnKure Therapeutics (NASDAQ:OKUR) Spend Its Cash Wisely? [Yahoo! Finance]
OnKure Therapeutics (NASDAQ: OKUR) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $35.00 to $30.00. They now have an "outperform" rating on the stock.
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences
Form 4 OnKure Therapeutics, For: Mar 31 Filed by: Mathers Edward T
Form 4 OnKure Therapeutics, For: Mar 31 Filed by: Manke Isaac
Form 424B3 OnKure Therapeutics,
Form EFFECT OnKure Therapeutics,
Form POS AM OnKure Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.